Building the Next Generation of MedTech Leaders
Exploring One Six 8 Ventures’ Portfolio
One Six 8 Ventures focuses on funding next-generation MedTech companies through a precision-based approach designed to minimize risk and unlock superior returns. We target exceptional deals in Canada while identifying unique global opportunities that align with our investment thesis.
Our team leverages deep scientific experience and operational expertise to source opportunities from a pipeline of 600 annual deals, often partnering alongside institutional co-investors. This selective approach allows us to identify companies with strong technical foundations, clear paths to commercialization, and significant potential for strategic acquisition.
We seek entrepreneurs who are developing solutions that address urgent healthcare needs, demonstrate technological differentiation, and can scale to meet global demand. Our portfolio reflects this disciplined focus on companies positioned to become category leaders in their respective fields.
Current Portfolio Companies
-
Fluid Biomed
Developing the world's first hybrid polymer-metal flow-diverting stent to provide a scaffold for enhanced vessel healing, effectively curing deadly brain aneurysms. Uniquely constructed of dissolving polymer and metal, this innovative medical device also allows for better visualization of blood vessels.
-
Pulse Medica
Pioneering a non-invasive, image-guided laser platform to safely screen and treat eye floaters and other vitreoretinal diseases, establishing a new standard of care through the use of next-generation femtosecond laser technology for precise treatment and imaging.
Our Unique MedTech Investment Approach
Our portfolio strategy centres on companies that demonstrate technical excellence, address substantial market opportunities, and maintain clear pathways to strategic value creation. We seek entrepreneurs who combine deep domain expertise with the ambition to build companies that transform healthcare delivery.
Through active partnership and strategic guidance, we work alongside our portfolio companies to accelerate development timelines, establish connections with strategic acquirers, and navigate the complex regulatory and commercial landscapes inherent to MedTech innovation. Our team's operational experience allows us to provide relevant support at each stage of company growth.
Partner with Experience
Meet our team to learn about the operators and executives guiding our portfolio companies, or get in touch to discuss potential investment opportunities.